In H1 2021 Olainfarm Group continues stable growth
The compiled financial indicators for the first six months of this year confirm the growth of Olainfarm Group. The financial performance measures of both Olainfarm and its subsidiaries have grown steadily, compared to the same period last year, which means that we are heading in the right direction. The pandemic has not affected our operations significantly either. Russia is still our biggest market, with a significant increase of medicine sales. Ukraine now is in the second place, while the usual second-largest market, Belarus, has dropped to the third position. Overall, financially we are on track with the budget and we are performing well,” Jānis Buks, Chairman of the Management Board of JSC Olainfarm.
In 2021, the Group continued the marketing and development of primary therapeutic area medicinal products. The most important therapeutic areas for the Group are medicine for health of nervous system, antibacterial medicine, medicine for cardiovascular health and anti-allergy medicine. Despite decline in all therapeutical categories across all markets, the top brands in neurology, cardiology, and anti-infectives outperform the market and gain market share in the relevant therapeutic categories.
In 2021, the Group continued its ongoing activity in major markets. The highest sales in six months in 2021 was in Latvia, reaching 19 684 thousand EUR, which is 552 thousand EUR or 3% more than the same period year ago. Latvia sales represent 30% in Group revenues.
Sales in Russia for the six months period in 2021 amount to 18 092 thousand EUR which is decrease by 1 601 thousand EUR or 8% compared to the last year, however the last year ratio includes EUR 9 million unexpected deliveries to Russia in June 2020 due to the announced serialization. Group subsidiary in Russia is actively operating, proceeding with established robust digital communication channels, created patient support programs for anxiety discussions, and developed educational platform for healthcare professionals.
During six months of 2021 the Group’s sales reached EUR 66 671 thousand, which is close to same period of last year. Gross profit was EUR 38 662 thousand, which shows decrease by 2 188 thousand EUR or 5% compared to same time period last year. Gross profit margin in reporting period is 58.0 %, which is 3.5 p.p. drop compared to 61.5 % reached same period last year.
The Group’s EBITDA figure for six months 2021 was EUR 12 129 thousand, which is 32 % or EUR 5 795 thousand EUR less than the result of the same period of 2020. EBITDA margin of the Group is 18.2 %.
Group Net profit is EUR 7 668 thousand, which is a drop by EUR 2 349 thousand or 23% versus same period of previous year.
The Group’s financial position during the first half of 2021 is stable. The Group’s successful operations allowed it to accumulate EUR 25 881 thousand in cash at the end of June 2021. According to the decision taken at Meeting of Shareholders on 18 June 2021, JSC “Olainfarm” has paid dividend EUR 2 394 thousand (0.17 EUR per share) on 12 July 2021.
The impact of Covid-19
Several of the Group companies used the opportunity provided by the Latvian State to receive financial support for Covid-19 crisis mitigation and the motivation of medical personnel. In total, in the first 6 months of 2021, the Group companies have received Latvian State financial support amounting to EUR 183 thousand.
Investments and development
In the first half of 2021, the planning of four Phase 3 clinical trials was performed and the necessary actions for the initiation of trials, which were planned to be started in 2021, in accordance with the limitations and risks related to the implementation of the Covid-19 pandemic.
In the 2nd quarter of 2021 enrollment of volunteers has started in Phase 3 clinical trial for the treatment of diseases of the peripheral nervous system.
JSC Olainfarm and Adalvo have signed a licensing and supply agreement to launch a new urology product in 17 countries in 2022 - 2023. Adalvo, a part of Alvogen Group, is one of the leading B2B pharmaceutical companies in Europe.
During the reporting period the investments mainly made in production, product development, IT and digitalization. Covid-19 pandemic restrictions and economic consequences significantly influenced the possibilities of the Group to realize planned investments.
Olainfarm, a part of Olainfarm Group, is one of the leading pharmaceutical companies in the Baltic States offering high quality medicine and chemical pharmaceutical products. The Group’s business strategy “FORWARD” highlights the main company’s vision – to become one of the TOP10 Central and Eastern European manufacturing companies by 2025.
With nearly 50 years of expertise, Olainfarm Group delivers sustainable healthcare products and services with added value to patients in more than 50 countries all over the world via its key subsidiaries – pharmaceutical company Olainfarm, food supplements & medical devices producer Silvanols, elastic & compression material producer Tonus Elast, pharmacy chain LatvijasAptieka and healthcare & diagnostics centresDiaMed & OlainMed.
Investor Relations Advisor of JSC Olainfarm
Phone: +371 29178878
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Benjamin Hill Releases Inaugural Drill Program Targeting Most Prospective Locations on the Sonora Gold Property22.9.2021 13:30:00 CEST | Press release
VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Benjamin Hill Mining Corp. (CSE: BNN) (OTCBB: BNNHF) (“BHM” or the “Company”) is pleased to announce their inaugural drill program for their never before drilled Sonora Gold property in the Caborca Gold belt of Sonora Mexico. The program consists of 80 strategic drill holes targeting the main mineralized structures in the Caracahui, Caracahui North, Sonora Copper, La Salada and Antenas exploration areas. The 80 sites were selected based on detailed mapping of mineralized structures and very encouraging surface sample assay results. Drill targets have been prioritized to assess areas where surface samples revealed the highest gold values and in locations that are accessible with minimal road building and ground disturbance (Figure 1). Benjamin Hill plans a phased approach to the drill program to maximize the value of the data collected. The exploration areas containing the best assays from surface sampling will be the focus
Millicom Announces Early Participation Results of and Increases the Maximum Acceptance Amount for the Exchange Offer22.9.2021 13:05:00 CEST | Press release
Millicom Announces Early ParticipationResults of and Increases the Maximum Acceptance Amount for the Exchange Offer Luxembourg, September 22, 2021 – In connection with its previously-announced offer to exchange (the “Exchange Offer”) its outstanding 6.625% Senior Notes due 20261 (the “2026 Existing Notes” or “Old Notes”) for 4.500% Senior Notes due 2031 (the “New Notes”), Millicom International Cellular S.A. (the “Company”) (NASDAQ U.S.: TIGO, Nasdaq Stockholm: TIGO_SDB) announces the results as of the Early Participation Date (as defined below) and increases the Maximum Acceptance Amount (as defined below) for the Exchange Offer to accept all 2026 Existing Notes that were validly tendered and not validly withdrawn by the Early Participation Date (as defined below). Early Participation Date Results The Early Participation Date with respect to the Exchange Offer occurred at 5:00 PM, New York City time, on September 21, 2021 (such time and date, the “Early Participation Date”). According
Van Lanschot Kempen: EGM agrees to Brigitte Boone’s appointment as a member of the Supervisory Board and takes note of the intention to appoint Maarten Edixhoven as a member and Chair of the Management Board22.9.2021 13:00:00 CEST | Press release
’s-Hertogenbosch/Amsterdam, the Netherlands, 22 September 2021 On 22 September 2021, Van Lanschot Kempen’s extraordinary general meeting (EGM) approved the appointment of Brigitte Boone as a member of its Supervisory Board. It was also officially advised of the intention to appoint Maarten Edixhoven as a member and Chair of the Management Board effective 1 October 2021. Frans Blom, Chair of the Supervisory Board, said: “We’re delighted with Brigitte’s appointment and wish her lots of success as a member of our Supervisory Board. On 1 October 2021, we’ll welcome Maarten as the company’s new CEO, which is also when we’ll bid farewell to our current Chair, Karl Guha. “Van Lanschot Kempen’s results and growth in the years under Karl’s leadership tell their own story, but our people’s engagement, entrepreneurialism and sheer drive are unparalleled. We’ll miss Karl as a director and manager, as a colleague, and most of all as a highly inspiring leader. And we are so grateful to him for headi
Solarisbank selects Feedzai as Risk Management Partner22.9.2021 12:53:53 CEST | Press release
Two fintech Unicorns join forces to shape the future of financial services and democratize access to banking in Europe AMSTERDAM, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Feedzai, the world’s leading cloud-based financial risk management platform, and Solarisbank AG, Europe's leading Banking-as-a-Service platform, announced today at Money20/20 Europe a multi-year partnership. The pioneering companies have joined forces to reshape banking, combining the trailblazing transformation that comes with Banking-as-a-Service with the risk management and security that is expected from financial institutions - all while preserving the customer experience. Importantly, the flexibility of Feedzai’s risk management solution means they can scale as Solarisbank grows, helping the company to keep up with a regulatory and geo-political landscape that is in a constant state of flux as well as more comprehensively protect customers from threats. Solarisbank enables any company to offer financial services via AP
Fobi Data Exchange Launches With First Partner, In-Touch Group, A Leading UK Platform Managing Data From 6,000 Independent Convenience Stores22.9.2021 12:00:00 CEST | Press release
In-Touch group will optimize Data With Fobi AI Driven Analytics And Monetize Through Global CPG Brands. Fobi Data Exchange (FDX) Delivers Analytics For Both Convenience Stores and CPG Brands Previously Thought Unattainable VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Fobi AI Inc. (FOBI: TSXV FOBIF: OTCQB) (the “Company” or “FOBI”), a global leader in providing real-time data analytics through artificial intelligence to drive operational efficiencies and profitability, is pleased to announce the launch of the Fobi Data Exchange (“FDX”) with its first data monetization agreement and partner, In-Touch Group, a provider of consumer insights and digital marketing to retailers and consumers. In-Touch currently manages a data lake of point-of-sale transactions for approximately 6,000 convenience stores, which is projected to increase to approximately 10,000 stores by the end of 2021. Through FDX, Fobi will optimize and monetize this data by providing Global CPG brands with
RESULT OF RIKSBANK REVERSED AUCTIONS TREASURY BILLS22.9.2021 11:07:00 CEST | Press release
Auction date2021-09-22 LoanDEC 2021IsinSE0015244405Coupon, %0.00Maturity2021-12-15 Tendered volume, SEK mln1,000 +/- 500Offered volume, SEK mln2,800 Volume bought, SEK mln1,000 Number of bids11 Number of accepted bids10 Average yield, %-0.238 %Lowest accepted yield, %-0.288 %Highest yield, %-0.205 %Accepted at lowest yield, %20.00 Auction date2021-09-22 LoanJUN 2022IsinSE0016102057Coupon, %0.00Maturity2022-06-15Tendered volume, SEK mln1,000 +/- 500Offered volume, SEK mln2,000 Volume bought, SEK mln1,000 Number of bids6 Number of accepted bids1 Average yield, %-0.288 %Lowest accepted yield, %-0.288 %Highest yield, %-0.288 %Accepted at lowest yield, %100.00 Auction date2021-09-22 LoanSEP 2022IsinSE0016787204Coupon, %0.00Maturity2022-09-21Tendered volume, SEK mln500 +/- 250Offered volume, SEK mln1,000 Volume bought, SEK mln500 Number of bids3 Number of accepted bids1 Average yield, %-0.311 %Lowest accepted yield, %-0.311 %Highest yield, %-0.311 %Accepted at lowest yield, %100.00
Result of Riksbank´s purchases of Commercial Paper22.9.2021 10:00:00 CEST | Press release
AuctionAuction resultsAuction date2021-09-22Settlement date2021-09-24Credit rating class1Term3mFixed purchase rate, %0.3Total bid amount, SEK mln0Accepted volume, SEK mln0Percentage alloted, %0Number of bids0 AuctionAuction resultsAuction date2021-09-22Settlement date2021-09-24Credit rating class1Term6mFixed purchase rate, %0.4Total bid amount, SEK mln0Accepted volume, SEK mln0Percentage alloted, %0Number of bids0 AuctionAuction resultsAuction date2021-09-22Settlement date2021-09-24Credit rating class2Term3mFixed purchase rate, %0.6Total bid amount, SEK mln0Accepted volume, SEK mln0Percentage alloted, %0Number of bids0 AuctionAuction resultsAuction date2021-09-22Settlement date2021-09-24Credit rating class2Term6mFixed purchase rate, %0.7Total bid amount, SEK mln0Accepted volume, SEK mln0Percentage alloted, %0Number of bids0